Neutral endopeptidase activity is not elevated in serum in children with cholestatic liver disease: a unique role of aminopeptidase-m in sequential hydrolysis of peptides.
The aim of this study was to determine whether neutral endopeptidase activity is elevated in serum in children with cholestatic liver disease (Alagille syndrome), and whether the enzyme cooperates with the serum aminopeptidase-M in degradation of peptides. Our data suggest that neutral endopeptidase activity remains at a very low level,.undetectable with the assays we have applied, both in the serum from healthy children and those with cholestasis. In contrast, the serum aminopeptidase-M activity is highly increased in cholestasis. We have demonstrated that aminopeptidase-M alone is capable of sequential and complete hydrolysis of enkephalins and low-molecular-weight, nonspecific peptides. The rate of release of free amino acids from both exogenous or endogenous substrate peptides was statistically significantly higher in serum in children with cholestasis compared with healthy children (P < 0.05). Substance P (Ki = 2.5 micromol/liter) and bradykinin (Ki = 27 micromol/liter) were shown to be potent inhibitors of the serum aminopeptidase-M. We postulate that aminopeptidase-M, except when regulating the activity of bioactive peptides, may serve as a scavenger of short, nonspecific peptides in the circulation. Our data seem to provide new insights for further studies on the role of serum peptidases both in physiology and pathophysiology.
Department of Radioimmunology, The Children's Memorial Health Institute, Warsaw, Poland.
Roman M
RM
Janas
Jerzy
J
Socha
Jadwiga
J
Janas
Krzysztof
K
Warnawin
D000293:Adolescent; D016738:Alagille Syndrome / Q000201:enzymology*; D001920:Bradykinin / Q000494:pharmacology; D018826:CD13 Antigens / Q000502:physiology*; D002648:Child; D002851:Chromatography, High Pressure Liquid; D004745:Enkephalins / Q000378:metabolism; D006801:Humans; D006868:Hydrolysis; D015260:Neprilysin / Q000097:blood*; D010455:Peptides / Q000378:metabolism*; D013373:Substance P / Q000494:pharmacology
D004745:Enkephalins; D010455:Peptides; D013373:Substance P; D018826:CD13 Antigens; D015260:Neprilysin; D001920:Bradykinin